Results 21 to 30 of about 42,502 (303)
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Hepatology, EarlyView., 2022 Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
South African Family Practice, 2015 Switching antidepressants because of lack of efficacy or unacceptable side effects, while often required in general practice, may result in toxic drug-drug interactions, worsening depression or unpleasant discontinuation reactions.
K. Outhoff
doaj +1 more source
Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression [PDF]
Yeungnam University Journal of Medicine, 2019 There is considerable overlap in the clinical presentations of apathy and depression. However, differential diagnosis between apathy and other psychiatric conditions, including depression and dementia, is important. In this report, we present the case of
Hye-Geum Kim +3 more
doaj +1 more source
Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk Syndrome
Biological Psychiatry Global Open Science, 2021 Background: Negative symptoms are diagnostic characteristics of schizophrenia. They can result from primary (i.e., idiopathic) or secondary (i.e., due to other factors such as depression, anxiety, psychosis, disorganization, medication effects) features ...
Tina Gupta +6 more
doaj +1 more source
Ibrain, EarlyView., 2023 This study compared the clinical effectiveness and treatment satisfaction of Pregabalin and Gabapentin triple therapy for neuropathic pain in a real‐world setting. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from baseline to 12 weeks posttreatment.
Nithya Raju +7 more
wiley +1 more source
Frontiers in Behavioral Neuroscience, 2022 Drug use is highly concordant among members of adolescent and young adult peer groups. One potential explanation for this observation is that drugs may increase the reinforcing effects of social contact, leading to greater motivation to establish and ...
Jessica L. Sharp, Mark A. Smith
doaj +1 more source
Duloxetine-induced rapid eye movement sleep behavior disorder: a case report
BMC Psychiatry, 2017 Background Tricyclic antidepressants and selective serotonin reuptake inhibitors have been reported to induce the symptoms of rapid eye movement (REM) sleep behavior disorder (RBD) or to exacerbate REM sleep without atonia.
Lu Tan +6 more
doaj +1 more source
Pharmaceutics, 2023 Serotoninergic signaling is identified as a crucial player in psychiatric disorders (notably depression), presenting it as a significant therapeutic target for treating such conditions.
Kapil Kumar Goel +5 more
doaj +1 more source
Kleptomania Induced by Venlafaxine
Case Reports in Psychiatry, 2021 Introduction. Kleptomania is an impulse-control disorder that results in an irresistible urge to steal. It is often observed as a comorbidity in patients undergoing pharmacological treatment for Parkinson’s disease.
Kumi Sakurada +4 more
doaj +1 more source
Divergent effect of fluoxetine on the response to physical or chemical stressors in zebrafish [PDF]
PeerJ, 2017 Fluoxetine is a selective serotonin reuptake inhibitor that increases serotonin concentration in the central nervous system and modulates various systems, including the control of sympathetic outflow and the hypothalamus–pituitary–adrenal. However, it is
Murilo S. Abreu +4 more
doaj +2 more sources